Oppenheimer Asset Management Inc. Bio Rad Laboratories, Inc. Transaction History
Oppenheimer Asset Management Inc.
- $7.94 Billion
- Q4 2024
A detailed history of Oppenheimer Asset Management Inc. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 2,714 shares of BIO stock, worth $708,869. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,714
Previous 2,669
1.69%
Holding current value
$708,869
Previous $892,000
0.11%
% of portfolio
0.01%
Previous 0.01%
Shares
27 transactions
Others Institutions Holding BIO
# of Institutions
478Shares Held
19.2MCall Options Held
15.7KPut Options Held
11.5K-
Vanguard Group Inc Valley Forge, PA1.92MShares$501 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$405 Million0.01% of portfolio
-
Wealthfront Advisers LLC1.04MShares$272 Million0.29% of portfolio
-
Veritas Asset Management LLP977KShares$255 Million3.36% of portfolio
-
Dimensional Fund Advisors LP Austin, TX746KShares$195 Million0.06% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $6.43B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...